欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
LT/H/0160/003
药品名称
Sunitinib Viasana
活性成分
SUNITINIB 50.0 mg
剂型
Capsule, hard
上市许可持有人
UAB Visana J. Jasinskio str. 17 Vilnius, LT-01111 Lithuania
参考成员国 - 产品名称
Lithuania (LT)
互认成员国 - 产品名称
Latvia (LV)
Estonia (EE)
许可日期
2022/01/25
最近更新日期
2022/01/25
药物ATC编码
L01XE04 sunitinib
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
PubAR
|
LT_H_0160_001_003_DC_PAR Scientific discussion_updated
Date of last change:2024/09/06
PubAR
|
LT_H_0160_001_003_DC_PAR Scientific discussion_updated_2
Date of last change:2024/09/06
PubAR
|
LT_H_0160_001_003_DC_PAR Summary_I_R_JA
Date of last change:2024/09/06
PubAR
|
LT_H_0160_001_003_DC_PAR Summary_I_R_JA_2
Date of last change:2024/09/06
Final Labelling
|
LT_H_0160_001_003_DC_Sunitinib Viasana_Labelling_ pack_20220125_cl
Date of last change:2024/09/06
Final PL
|
LT_H_0160_001_003_DC_Sunitinib Viasana_PL_20220125_cl
Date of last change:2024/09/06
Final SPC
|
LT_H_0160_001_003_DC_Sunitinib Viasana_SPC_20220125_cl
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase